CARL ZEISS MEDITEC ADR 1 (AFXA) — Defensive Interval Ratio

Latest as of September 2025: 140 days

CARL ZEISS MEDITEC ADR 1 (AFXA) has a Defensive Interval Ratio of 140 days as of September 2025. Defensive assets of €209.01 Million (cash €-, short-term investments €-, receivables €209.01 Million) cover 140 days of daily cash needs of €1.49 Million/day. Check AFXA tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

140 days
Days of operational coverage

Defensive Assets

€209.01 Million
Cash + ST Investments + Receivables

Daily Cash Need

€1.49 Million
Current Liabilities ÷ 365

Current Liabilities

€543.81 Million
EUR

CARL ZEISS MEDITEC ADR 1 Defensive Interval Ratio (2022–2025)

This chart shows how CARL ZEISS MEDITEC ADR 1's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 140 days, meaning defensive assets of €209.01 Million can fund 140 days of operations without new revenue. Also explore CARL ZEISS MEDITEC ADR 1 equity growth rate to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for CARL ZEISS MEDITEC ADR 1 (2022–2025)

The table below presents the year-by-year Defensive Interval Ratio for CARL ZEISS MEDITEC ADR 1 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of CARL ZEISS MEDITEC ADR 1.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 140 days €209.01 Million €1.49 Million/day €- €- ▲ +6 days
2024 134 days €209.05 Million €1.56 Million/day €- €- ▲ +6 days
2023 128 days €196.92 Million €1.54 Million/day €- €- ▼ -6 days
2022 134 days €197.80 Million €1.48 Million/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)